Evidence map›Paper›PMID 26051508›Full record

Trial reportPrevention science : the official journal of the Society for Prevention Research2015

Effects of Personalized Feedback Interventions on Drug-Related Reoffending: a Pilot Study.

Kenji Yokotani, Katsuhiro Tamura

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Prevention science : the official journal of the Society for Prevention Research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Kenji YokotaniNiigata Prison, Niigata-shi, Niigata, 951-8121, Japan. yokotani@n-seiryo.ac.jp.
Katsuhiro TamuraNiigata Prison, Niigata-shi, Niigata, 951-8121, Japan.
Niigata Agricultural Research Institute · JPNiigata Seiryo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Addiction is serious problem that requires effective treatment. Previous studies support personalized feedback interventions (PFIs) as an effective treatment for drinking; however, the potential beneficial effects of this treatment on illegal drug use have not been explored. The present study examined the effects of PFIs in a sample of repetitive drug-related offenders. Participants were 50 repetitive drug-related offenders incarcerated in a Japanese prison. They were randomly assigned to the PFIs (n = 20) or control (n = 30) group. The PFIs group received six letters for 3 months, whereas the control group did not undergo any interventions. We defined relapse and recidivism as drug-related reoffending and reentering prison after release, respectively. In the 3.6-year follow-up analysis (range, 0.1-5.8 years), participants' criminal records were examined, and results indicated a decreased risk of relapse and recidivism for the PFIs group relative to the control group, even when controlling for age, educational level, number of prison terms, and sentence length. Thus, our findings suggest that PFIs reduce the likelihood of relapse and recidivism in drug-related offenders.

Indexed as

FeedbackAdultHealth PromotionHumansJapanMaleMiddle AgedPilot ProjectsPrecision MedicineSecondary PreventionSelf ReportSubstance-Related DisordersAmphetamineDrug-related reoffendingMethamphetaminePersonalized feedback interventionRecidivism

Identifiers

PMID26051508
OpenAlexW1861846229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.